Pfizer NSE 0.00 % said it is exploring potential contract manufacturing options to help ensure access across low- and middle-income countries, including India, to supply its Covid-19 antiviral drug Paxlovid. The company didn't specify the companies it is in touch with for manufacturing of the antiviral drug.
A Pfizer company spokesperson told ET that the company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of making treatment courses available as quickly as possible, pending authorisation.
"We expect to use our strong manufacturing capabilities and our extensive supplier network to improve output rapidly," the spokesperson said.
Read more at: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-nod-in-hand-pfizer-is-looking-for-partners-to-make-covid-drug-in-india/articleshow/88442898.cms
Comments